Home
Conferences:
MedPharm Limited will be attending the following events:
Rodman and Renshaw - NY, USA - 9-10 September 2012
CPHI - Madrid, Spain - 9-11 October 2012
AAPS - Annual Meeting and Exposition - Chicago, USA - 14-18 October 2012
BIO Europe - Hamburg, Germany - 12-14 November 2012
AAD - The American Academy of Dermatology's Annual Meeting - Miami Beach, Fl. -March 1-5, 2013
We invite you to meet with us at any of the events mentioned. To arrange a meeting or for any further information, please contact: The Business Development Team
01/01/70
Latest News
MedPharm Granted New Patent in Russia for MedSpray®
MedPharm Ltd have been granted a patent in Russia for their MedSpray® drug delivery technology.
Journal of Controlled Release
MedPharm’s MedRo technology features in the journal as being a new opportunity in the area of...
South East Business Article
Innovators - Our monthly look to see whos pushing the boundaries.
This month - MedPharm Ltd
MedPharm completes License Agreement for MedSpray®
MedPharm completes License Agreement with Sinclair Pharma for Terbinafine MedSpray®
MedPharm Granted New Patent in China for MedSpray®
Patent introduces stepping stone for specialist topical company into Chinese and Asian markets
MedPharm: Your partner in topical drug delivery and formulation.
Drug Delivery with a Difference.
MedPharm is a private drug delivery and contract service company committed to the creation and development of novel systems, particularly for topical drug formulations for delivery to the skin, nail, mucous membranes, eye, nose and lung.
We have a reputation for success with formulating difficult compounds especially in the area of topical drug delivery.
With over 100 customers worldwide, MedPharm offers a unique and highly specialized service in pharmaceutical contract research and development, and expert project management from feasibility tests, dosage design and optimization, to preparation of GMP clinical supplies trials, in conjunction with our manufacturing partners (plus check our announcement on our new GMP suite due end of 2011), and preclinical (GLP and non-GLP) and clinical evaluation.
MedPharm has a substantial patent portfolio of novel drug delivery systems. These technologies are available as part of our service offering or as stand-alone licences to third parties.
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by MedPharm Limited and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of MedPharm Limited. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, MedPharm Limited takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.